ZA200003034B - Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ZA200003034B
ZA200003034B ZA200003034A ZA200003034A ZA200003034B ZA 200003034 B ZA200003034 B ZA 200003034B ZA 200003034 A ZA200003034 A ZA 200003034A ZA 200003034 A ZA200003034 A ZA 200003034A ZA 200003034 B ZA200003034 B ZA 200003034B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
bicyclic amino
formula
Prior art date
Application number
ZA200003034A
Other languages
English (en)
Inventor
Guillaume De Nanteuil
Phillipe Gloanec
Tony Verbueren
Alain Rupin
Marie-Odile Vallez
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA200003034B publication Critical patent/ZA200003034B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200003034A 1999-06-15 2000-06-15 Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them. ZA200003034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907538A FR2795072B1 (fr) 1999-06-15 1999-06-15 Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200003034B true ZA200003034B (en) 2001-01-11

Family

ID=9546789

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200003034A ZA200003034B (en) 1999-06-15 2000-06-15 Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (23)

Country Link
US (1) US6277851B1 (ja)
EP (1) EP1069132B1 (ja)
JP (1) JP3364472B2 (ja)
KR (1) KR100456796B1 (ja)
CN (1) CN1147489C (ja)
AT (1) ATE251177T1 (ja)
AU (1) AU766194B2 (ja)
BR (1) BR0002643A (ja)
CA (1) CA2312206C (ja)
DE (1) DE60005609T2 (ja)
DK (1) DK1069132T3 (ja)
EA (1) EA003209B1 (ja)
ES (1) ES2208239T3 (ja)
FR (1) FR2795072B1 (ja)
HK (1) HK1032236A1 (ja)
HU (1) HUP0002277A3 (ja)
NO (1) NO316650B1 (ja)
NZ (1) NZ505149A (ja)
PL (1) PL199522B1 (ja)
PT (1) PT1069132E (ja)
SE (1) SE1069132T5 (ja)
SI (1) SI1069132T1 (ja)
ZA (1) ZA200003034B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245356A1 (en) * 2000-02-29 2001-09-12 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003243657A1 (en) * 2002-06-26 2004-01-19 Bristol-Myers Squibb Company Amino-bicyclic pyrazinones and pyridinones
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20140350034A1 (en) * 2012-01-27 2014-11-27 Novartis Ag Aminopyridine derivatives as plasma kallikrein inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
HUT77651A (hu) * 1994-12-22 1998-07-28 Biochem Pharma Inc. Oxazolo- és tiazolo[3,2-a]piridin-, pirrolo[1,2-a]pirazin- és pirido[2,1-c][1,4]tiazin-karboxamido-arginin-származékok, eljárás ezek előállítására és az ezeket tartalmazó gyógyszerkészítmények
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
EP0923372A4 (en) * 1996-02-22 2001-09-05 Merck & Co Inc PYRIDINONE THROMBINE INHIBITORS
AU3232597A (en) * 1996-06-18 1998-01-07 Warner-Lambert Company Pyrrolo{1,2-a}pyrazine-1,4-dione serine protease inhibitors
AU4172397A (en) * 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
DE69719775T2 (de) * 1996-10-24 2004-02-05 Merck & Co., Inc. Thrombin inhibitoren
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
EP1017383A4 (en) * 1997-09-23 2001-11-28 Merck & Co Inc THROMBIN INHIBITORS

Also Published As

Publication number Publication date
PL199522B1 (pl) 2008-09-30
EP1069132B1 (fr) 2003-10-01
DK1069132T3 (da) 2004-02-02
HU0002277D0 (en) 2000-08-28
ATE251177T1 (de) 2003-10-15
CA2312206A1 (fr) 2000-12-15
AU766194B2 (en) 2003-10-09
AU4086500A (en) 2000-12-21
FR2795072A1 (fr) 2000-12-22
SE1069132T5 (sv) 2004-01-07
DE60005609T2 (de) 2004-08-05
SE1069132T3 (sv) 2003-12-09
EA200000527A2 (ru) 2000-12-25
US6277851B1 (en) 2001-08-21
NO20002941D0 (no) 2000-06-08
HUP0002277A2 (hu) 2001-05-28
EA003209B1 (ru) 2003-02-27
HUP0002277A3 (en) 2002-12-28
CN1147489C (zh) 2004-04-28
EA200000527A3 (ru) 2001-04-23
ES2208239T3 (es) 2004-06-16
DE60005609D1 (de) 2003-11-06
KR20010066846A (ko) 2001-07-11
NO316650B1 (no) 2004-03-22
FR2795072B1 (fr) 2001-07-27
JP3364472B2 (ja) 2003-01-08
PL340784A1 (en) 2000-12-18
JP2001026592A (ja) 2001-01-30
CA2312206C (fr) 2004-07-06
HK1032236A1 (en) 2001-07-13
CN1277198A (zh) 2000-12-20
SI1069132T1 (en) 2003-12-31
EP1069132A1 (fr) 2001-01-17
NZ505149A (en) 2001-01-26
BR0002643A (pt) 2001-01-02
KR100456796B1 (ko) 2004-11-10
PT1069132E (pt) 2004-02-27
NO20002941L (no) 2000-12-18

Similar Documents

Publication Publication Date Title
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
TW200612920A (en) Novel imidazolidine derivatives
NO950849L (no) Derivater av valproin og 2-valproensyreamider og anvendelse som antikonvulsanter
AU1463195A (en) Substituted aromatic compounds as c.amp phosphodiesterase- and tnf-inhibitors
MXPA05007496A (es) Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
EA200600487A1 (ru) Соединения инданилпиперазина, способ их получения и содержащие их фармацевтические композиции
EA200000792A3 (ru) Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
HU0002277D0 (en) Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them
DK0635497T3 (da) Benzospiroalkenderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse
NZ514758A (en) Cyclobutenedione compounds to treat conditions in which endothelial dysfunction is known
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
EA200101204A1 (ru) Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции
ATE63306T1 (de) Indolderivate.
NO20026004D0 (no) Nye podofyllotoksinkarbamat- og tiokarbamatforbindelser, fremgangsmåte vedderes fremstilling og farmasöytiske sammensetninger inneholdendedem
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
HUP0102350A2 (hu) Propenil-cefalosporin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
HU902079D0 (en) Process for producing glutaric acid derivatives and pharmaceutical preparatives containing such compounds
HU9603178D0 (en) Process for producing benzyl-ethers with phase transformation
HK1053793A1 (en) Pharmaceutical compositions containing oxapenem-3-carboxilic acids
NZ508141A (en) Substituted dithio-bis-nitrobenzenes and their use as screening inhibitors of NAD(P)H-dependent disulphide reductase enzymes
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
NO20023023L (no) Nye 3-imino-1,2-ditiolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem